Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent

Nature Nanotechnology

Volumn 4, Issue 7, 2009, Pages 457-463

  Liu, Lihong ^a,d   Xu, Kaijin ^b   Wang, Huaying ^b   Jeremy Tan, P K ^a   Fan, Weimin ^b,c   Venkatraman, Subbu S ^d   Li, Lanjuan ^b   Yang, Yi Yan ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; CELL MEMBRANES; CORE SHELL NANOPARTICLES; DRUG DELIVERY; MAMMALS; NANOPARTICLES; PEPTIDES; SELF ASSEMBLY;

AMPHIPHILIC PEPTIDES; ANTI-MICROBIAL PROPERTIES; BACTERIAL CELL SURFACE; BLOOD-BRAIN BARRIER; CATIONIC PEPTIDES; INFECTIOUS DISEASE; NEGATIVELY CHARGED; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL AGENTS;

AMPHOPHILE; ANTIINFECTIVE AGENT; CHOLESTEROLGLYCYLGLYCYLGLYCYLARGINYLARGINYLARGINYLARGINYLARGINYL ARGINYLTHREONYLALANYLTHREONINE; NANOPARTICLE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BRAIN TISSUE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; ENTEROCOCCUS FAECALIS; FEMALE; GROWTH INHIBITION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; LETHAL DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICELLE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NANOFABRICATION; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RABBIT; REPEATED DRUG DOSE; SOLID PHASE SYNTHESIS; STACHYBOTRYS CHARTARUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 67651229209     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2009.153     Document Type: Article

References (32)

1. Obermaier, B., Klein, M., Koedel, U. & Pfister, H. W. Disease models of acute bacterial meningitis. Drug Discov. Today 3, 105-112 (2006).
2. Ewald, C., Kuhn, S. & Kalff, R. Pyogenic infection of the central nervous system secondary to dental affection - a report of six cases. Neurosurg. Rev. 29, 163-167 (2006).
3. Bert, F., Ouahes, O. & Lambert-Zechovsky, N. Brain abscess due to Bacillus macerans following a penetration periorbital injury. J. Clin. Microbiol. 33, 1950-1953 (1995).
4. Jafari, H. S. et al. Effects of antifungal therapy on inflammation, sterilization and histology in experimental Candida albicans meningitis. Antimicrob. Agents Chemother. 38, 83-89 (1994).
5. Casado, J. L. et al. Candidal meningitis in HIV-infected patients: analysis of 14 cases. Clin. Infect. Dis. 25, 673-676 (1997).
6. Islam, Z., Harkema, J. R. & Pestka, J. J. Satratoxin G from the black mold Stachybotrys chartarum evokes olfactory sensory neurons loss and inflammation in the murine nose and brain. Environ. Health Perspect. 114, 1099-1107 (2006).
7. Hancock, R. E. W. & Sahl, H. G. Antimicrobial and host-defence peptides as new anti-infective therapeutic strategies. Nature Biotechnol. 24, 1551-1557 (2006).
8. Oren, Z. et al. Structures and mode of membrane interaction of a short α helical lytic peptide and its diastereomer determined by NMR, FTIR and fluorescence spectroscopy. Eur. J. Biochem. 269, 3869-3880 (2002).
9. Oren, Z. & Shai, Y. Cyclization of a cytolytic amphipathic α-helical peptide and its diastereomer: effect on structure, interaction with model membranes and biological function. Biochemistry 39, 6103-6114 (2000).
10. Shai, Y. Mode of action of membrane active antimicrobial peptides. Biopolymers (Pept. Sci.) 66, 236-248 (2002).
11. Fernandez-Lopez, S. et al. Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature 412, 452-455 (2001).
12. Avrahami, D. & Shai, Y. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly and cell selectivity. Biochemistry 41, 2254-2263 (2002)
13. Vives, E., Brodin, P. & Lebleu, B. A truncated HIV-1 TAT protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017 (1997).
14. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G. & Dowdy, S. F. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477 (2001).
15. Fawell, S. et al. TAT-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA 91, 664-668 (1994).
16. Turner, J. J. et al. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol. Dis. 38, 1-7 (2007).
17. Pappalardo, J. S. et al. Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes. J. Control. Rel. 134, 41-46 (2009).
18. Schwarze, S. R., Ho, A., Vocero-Akbani, A. & Dowdy, S. F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572 (1999).
19. Santra, S. et al. Rapid and effective labeling of brain tissue using TAT-conjugated CdS: Mn/ZnS quantum dots. Chem. Commun. 25, 3144-3146 (2005).
20. Liu, L. H. et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 29, 1509-1517 (2008).
21. Futaki, S. et al. Arginine rich peptides: an abundant source of membrane permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840 (2001).
22. Wender, P. A. et al. The design, synthesis and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 13003-13008 (2000).
23. Weiss, R. G. Thermotropic liquid crystals as reaction media for mechanistic investigations. Tetrahedron 44, 3413-3475 (1988).
24. Lee, M., Rentz, J., Han, S.-O., Bull, D. A. & Kim, S. W. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Therapy 10, 585-593 (2003).
25. Li, C., Peters, A. S., Meredith, E. L., Allman, G. W. & Savage, P. B. Design and synthesis of potent sensitizers of gram-negative bacteria based on a cholic acid scaffolding. J. Am. Chem. Soc. 120, 2961-2962 (1998).
26. Dai, S., Ravi, P., Leong, C. Y., Tam, K. C. & Gan, L. H. Synthesis and aggregation behavior of amphiphilic block copolymers in aqueous solution: di- and tri-block copolymers of poly(ethylene oxide) and poly(ethyl acrylate). Langmuir 20, 1597-1604 (2004).
27. Whittaker, M. R., Urbani, C. N. & Monteiro, M. J. Synthesis of linear and 4-arm star block copolymers of poly(methyl acrylate-b-solketal acrylate) by SET-LRP at 25 °C. J. Polym. Sci. A 46, 6346-6357 (2008).
28. Jung, H. J., Park, Y., Hahm, K. S. & Lee, D. G. Biological activity of TAT (47-58) peptide on human pathogenic fungi. Biochem. Biophys. Res. Commun. 345, 222-228 (2006).
29. Hyde, A. J., Parisot, J., McNichol, A. & Bonev, B. B. Nisin-induced changes in Bacillus morphology suggest a paradigm of antibiotic action. Proc. Natl Acad. Sci. USA 103, 19896-19901 (2006).
30. Cho, S. et al. Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins. Proc. Natl. Acad. Sci. USA 104, 8761-8766 (2007).
31. Chan, D. I., Prenner, E. J. & Vogel, H. J. Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action. Biochim. Biophys. Acta 1758, 1184-1202 (2006).
32. Neuwelt, E. A. Mechanisms of disease: the blood-brain barrier. Neurosurgery 54, 131-141 (2004).